{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":324,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-09-14T18:21:24.973502+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"A Rescue Model For Shelved Drug Candidates With Annette Bakker, Ph.D. And Andrew Lo, Ph.D.","slug":"a-rescue-model-for-shelved-drug-candidates-with-annette-bakker-ph-d-and-andrew-lo-ph-d","published_at":"2026-08-03T10:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/a-rescue-model-for-shelved-drug-candidates-with-annette-bakker-ph-d-and-andrew-lo-ph-d","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/19570029-a-rescue-model-for-shelved-drug-candidates-with-annette-bakker-ph-d-and-andrew-lo-ph-d.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/19570029-a-rescue-model-for-shelved-drug-candidates-with-annette-bakker-ph-d-and-andrew-lo-ph-d.mp3","summary":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Annette Bakker, Ph.D., CEO at the Children's Tumor Foundation, and Andrew Lo, Ph.D., Finance Professor at MIT's Sloan School of Management and Director of the Laboratory for Financial Engineering, talk about the methods and economics for turning abandoned drug candidates into new therapies for patients. Annette and Andrew share the story of Gomekli, a formerly shelved Pfizer drug candida...","meta_description":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Annette Bakker, Ph.D., CEO at the Children's Tum…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3343,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/a-rescue-model-for-shelved-drug-candidates-with-annette-bakker-ph-d-and-andrew-lo-ph-d/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/a-rescue-model-for-shelved-drug-candidates-with-annette-bakker-ph-d-and-andrew-lo-ph-d.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}